FTDI
PACB icon

First Trust Direct Indexing’s Pacific Biosciences PACB Stock Holding History

First Trust Direct Indexing’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,816
Closed -$38.8K – 645
2024
Q3 		$38.8K Sell
22,816
-31,509
-58% -$51.8K ﹤0.01% 976
2024
Q2 		$74.4K Buy
54,325
+28,073
+107% +$56.7K ﹤0.01% 892
2024
Q1 		$98.4K Buy
+26,252
New +$154K 0.01% 782

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Direct Indexing's PACB Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Pacific Biosciences (PACB) in Q4 2024, closing a stake of 22,816 shares — an estimated $38.8K sold.

First Trust Direct Indexing first reported a position in PACB in Q1 2024 and held it in 3 quarters. The position peaked at $98.4K in Q1 2024. 226 funds tracked by Wall St. Rank hold PACB as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Pacific Biosciences position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 22,816 Pacific Biosciences shares in Q4 2024, an estimated $38.8K.
  • First Trust Direct Indexing first reported a position in Pacific Biosciences in Q1 2024 and held it in 3 quarters.
  • First Trust Direct Indexing's Pacific Biosciences position peaked at $98.4K in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.